

ENZ-CHM362 · 25 mg
Enzo · Cat: ENZ-CHM362
Reach 3+ verified distributors
Manufacturer product page
enzo.com/product/abt-263-2/
Description
ABT-263, also known as Navitoclax, is a potent and orally bioavailable inhibitor of the Bcl-2 family proteins, specifically targeting Bcl-2, Bcl-xL, and Bcl-w with Ki values of 0.5 nM, 1 nM, and 1 nM, respectively.







